News and Trends 17 Aug 2022
Palisade Bio announces closing of $13.8M upsized underwritten public offering
A biopharma company advancing therapies for acute and chronic gastrointestinal (GI) complications has announced today (August 17) the closing of its previously announced underwritten public offering for $13.8 million. An…